Reference
Minari R, et al. Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report. Translational Lung Cancer Research 9: 787-792, No. 3, Jun 2020. Available from: URL: http://doi.org/10.21037/tlcr.2020.04.03
Rights and permissions
About this article
Cite this article
Alectinib/crizotinib. Reactions Weekly 1829, 23 (2020). https://doi.org/10.1007/s40278-020-85613-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85613-6